Ignite Creation Date:
2025-12-26 @ 10:17 PM
Ignite Modification Date:
2026-01-24 @ 2:46 AM
Study NCT ID:
NCT00216112
Status:
COMPLETED
Last Update Posted:
2016-02-19
First Post:
2005-09-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer
Sponsor:
Organization: